Crossmark

Investigating the Predictive Validity of the Quantitative Checklist for Autism in Toddlers and the Autism Diagnostic Observation Schedule-2 in Children at Elevated Likelihood for Autism

Crossref DOI link: https://doi.org/10.1007/s10803-024-06585-y

Published Online: 2024-10-13

Published Print: 2026-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Schaubroeck, Sarah https://orcid.org/0000-0001-5094-2395
Demurie, Ellen

Begum-Ali, Jannath

Bölte, Sven

Boterberg, Sofie

Buitelaar, Jan

Charman, Tony

Falck-Ytter, Terje

Hunnius, Sabine

Johnson, Mark

Jones, Emily

Pasco, Greg

Van den Boomen, Carlijn

Warreyn, Petra

Roeyers, Herbert
Funding

Funding for this research was provided by:

Medical Research Council (G0701484)

Medical Research Council (MR/K021389/1)

Medical Research Council (MR/T003057/1)

Innovative Medicines Initiative (777394)

Innovative Medicines Initiative (115300)

HORIZON EUROPE European Research Council (642990)

Wellcome Trust

Marguerite-Marie Delacroix foundation

European Federation of Pharmaceutical Industries and Associations

Autism Speaks

Seventh Framework Programme (FP7/2007 - 2013)

Fonds Wetenschappelijk Onderzoek (12Z8821N)

Autistica

Simons Foundation Autism Research Initiative
License Information

Text and Data Mining valid from 2024-10-13

Version of Record valid from 2024-10-13
More Information

Article History

Accepted: 23 September 2024

First Online: 13 October 2024

Change Date: 9 January 2026

Change Type: Update

Change Details: This article was originally published under the subscription model but it is now published under an Open Access license.

Declarations

:

: Tony Charman has served as a paid consultant to F. Hoffmann-La Roche Ltd. and Servier and receives royalties from Sage Publications and Guilford Publications. Sven Bölte discloses that he has in the last 3 years acted as an author, consultant, or lecturer for Medice and LinusBio. He receives royalties for textbooks and diagnostic tools from Hogrefe, UTB, Ernst Reinhardt, Kohlhammer, and Liber. Sven Bölte is partner NeuroSupportSolutions International AB.

: Ethical approval was given by local ethics committees in participating countries and were conducted in accordance with the Declaration of Helsinki (2000) and the American Psychological Association. Participation was voluntary and GDPR regulation (2016/679) was strictly followed.

: Informed consent was obtained of parents of all participants included in this study.

Document is current

Any future updates will be listed below